KoBioLabs, Inc.

Australia is becoming a clinical trial hot spot for South Korean biotech and pharma firms, with companies such as PharmAbcine, Inc. , KoBioLabs, Inc. and Daewoong Pharmaceutical Company Ltd. incr

Investors and potential partners will need to keep their eyes firmly on the South Korean microbiome sector in 2022 as the moment of truth may be approaching. Bioventures including KoBioLabs, Inc. an

South Korean health authorities continued to focus on policies to control and ease the COVID-19 pandemic situation in 2021 through adjusting quarantine measures, securing vaccines and raising vaccinat

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CJ CheilJedang Acquires Batavia To Expa